Press Releases Danaher Corporation

Equities

DHR

US2358511028

Market Closed - Nyse Other stock markets 04:00:02 2024-05-02 pm EDT			5-day change	1st Jan Change
246.8 ^USD	-0.02%		-1.43%	+6.70%

Apr. 29	Raymond James Adjusts Price Target on Danaher to $285 From $270, Keeps Outperform Rating	MT
Apr. 26	Danaher Insider Sold Shares Worth $5,618,569, According to a Recent SEC Filing	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novartis, Danaher rise; Nucor, Cadence Design Systems fall, Tuesday, 4/23/2024	Apr. 23	AQ
Danaher: Q1 Earnings Snapshot	Apr. 23	AQ
Danaher Reports First Quarter 2024 Results	Apr. 23	PR
Danaher Schedules First Quarter 2024 Earnings Conference Call	Mar. 21	PR
Danaher to Present at TD Cowen Health Care Conference	Feb. 27	PR
Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets	Feb. 22	PR
Danaher Announces Quarterly Dividend	Feb. 21	PR
Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development	Feb. 05	PR
Danaher: Q4 Earnings Snapshot	Jan. 30	AQ
Danaher Reports Fourth Quarter and Full Year 2023 Results	Jan. 30	PR
Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution	Jan. 09	PR
Danaher CEO to Comment on Financial Performance	Jan. 08	PR
Danaher to Present at J.P. Morgan Healthcare Conference	Jan. 02	PR
Danaher Schedules Fourth Quarter 2023 Earnings Conference Call	Dec. 21	PR
Danaher Announces Quarterly Dividend	Dec. 05	PR
Danaher to Present at Evercore ISI HealthCONx Conference	Nov. 21	PR
Abcam Acquisition by Danaher has received all Identified Clearances, Transaction Expected to Close on December 6, 2023	Nov. 20	AQ
Danaher appoints Christopher Riley to Executive Vice President for Biotechnology	23-10-31	PR
Danaher : 2023 Q3 Non-GAAP RecsNon-GAAP RecsNon-GAAP Recs	23-10-24	PU
Danaher : 2023 Q3 PresentationPresentationPresentation	23-10-24	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Danaher Corporation

Equities

DHR

US2358511028

Press Releases

Filters